Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 25 Neoplasms 14 Colorectal Neoplasms 14 Melanoma 12 Carcinoma, Renal Cell 11 Neoplasm Metastasis 9 Solid Tumors 8 Carcinoma, Hepatocellular 8 Head and Neck Neoplasms 7 Urinary Bladder Neoplasms 6 Triple Negative Breast Neoplasms 6 Stomach Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Small Cell Lung Carcinoma 6 Ovarian Neoplasms 6 Lung Neoplasms 6 Carcinoma, Transitional Cell 6 Breast Neoplasms 6 Uterine Cervical Neoplasms 5 Lymphoma 5 Kidney Neoplasms 4 Endometrial Neoplasms 4 Solid Tumor 3 Pancreatic Neoplasms 3 Lymphoma, Non-Hodgkin 3 Advanced Solid Tumors 3 Urologic Neoplasms 2 Treatment-Refractory Solid Tumors 2 Solid Cancers 2 Recurrence 2

Interventions

Cyclophosphamide 14 Gemcitabine 6 Filgrastim 6 fludarabine 5 Methotrexate 5 Leucovorin 5 Granulocyte Colony-Stimulating Factor 5 Zoledronic Acid 4 Temozolomide 4 Mesna 4 Irinotecan 4 Ifosfamide 4 Etoposide 4 Cisplatin 4 Carboplatin 4 pembrolizumab 3 fludarabine phosphate 3 Doxorubicin 3 Biopsy 3 tanespimycin 2 poly ICLC 2 pegfilgrastim 2 lorukafusp alfa 2 liposomal doxorubicin 2 dinutuximab 2 cabozantinib 2 belinostat 2 Topotecan 2 Thalidomide 2 Specimen Handling 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Osteosarcoma × atezolizumab × Clear all

NCT06492954 2026-06-02

AflacST2301

Emory University

Phase 1 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡